ASH 2021 Updates: MDS and Secondary AML | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

ASH 2021 Updates: MDS and Secondary AML

Acute Myeloid Leukemia (AML)
Presentation Date: 
Mon, 05/09/2022 - 1:30pm (EDT)

In this webinar, Dr. Elizabeth Griffiths discusses research most relevant to patients reported over the past year on the biology and treatment on MDS and secondary AML. These studies were presented at the American Society of Hematology (ASH) 2021 meeting in Atlanta, GA. Research findings are explained along with the potential impact of this research on understanding and treating MDS and AML. This is an advanced scientific presentation.